Literature DB >> 17655502

Involvement of Kupffer cell-dependent signaling in T3-induced hepatocyte proliferation in vivo.

Virginia Fernández1, Solange Reyes, Sergio Bravo, Rodrigo Sepúlveda, Pamela Romanque, Gonzalo Santander, Iván Castillo, Patricia Varela, Gladys Tapia, Luis A Videla.   

Abstract

Thyroid hormone-induced calorigenesis triggers liver oxidative stress with concomitant TNF-alpha production by Kupffer cells and up-regulation of gene expression. Considering that cyclin-dependent kinase-2 (CDK-2) performs essential functions for cellular proliferation, our aim was to test the hypothesis that l-3,3',5-triiodothyronine (T(3)) stimulates liver cell proliferation by upstream mechanisms involving CDK-2 expression dependent on Kupffer cell signaling. T(3) administration induced a calorigenic response at 60-70 h after treatment, with increased TNF-alpha generation and hepatic oxidative stress status, as shown by enhanced protein carbonyls and decreased glutathione content compared to controls. In this time interval, liver c-jun N-terminal kinase (JNK) phosphorylation, activator protein-1 (AP-1) DNA binding, and CDK-2 expression were enhanced, with concomitantly higher levels of the proliferation markers Ki-67 and proliferating cell nuclear antigen. These changes are abolished by administration of the Kupffer cell inactivator gadolinium chloride prior to T(3) treatment. We conclude that T(3) administration triggers liver CDK-2 expression and cellular proliferation through a cascade associated with Kupffer cell-dependent TNF-alpha generation, JNK phosphorylation, and AP-1 activation. Since CDK-2 promotes phase S progression within the cell cycle, this response may constitute a major mechanism involved in T(3)-induced liver preconditioning to ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655502     DOI: 10.1515/BC.2007.101

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

1.  Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms.

Authors:  Luis A Videla
Journal:  World J Hepatol       Date:  2009-10-31

2.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

3.  Thyroid hormone-induced cytosol-to-nuclear translocation of rat liver Nrf2 is dependent on Kupffer cell functioning.

Authors:  Luis A Videla; Pamela Cornejo; Pamela Romanque; Catherine Santibáñez; Iván Castillo; Romina Vargas
Journal:  ScientificWorldJournal       Date:  2011-12-20

4.  Anti-Apoptotic Effects of 3,3',5-Triiodo-L-Thyronine in the Liver of Brain-Dead Rats.

Authors:  Rolando A Rebolledo; Anne C Van Erp; Petra J Ottens; Janneke Wiersema-Buist; Henri G D Leuvenink; Pamela Romanque
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

Review 5.  Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2019-07-08       Impact factor: 6.832

Review 6.  Mesenchymal stromal cells promote liver regeneration through regulation of immune cells.

Authors:  Chenxia Hu; Zhongwen Wu; Lanjuan Li
Journal:  Int J Biol Sci       Date:  2020-01-22       Impact factor: 6.580

Review 7.  Metabolic basis for thyroid hormone liver preconditioning: upregulation of AMP-activated protein kinase signaling.

Authors:  Luis A Videla; Virginia Fernández; Pamela Cornejo; Romina Vargas
Journal:  ScientificWorldJournal       Date:  2012-07-31

Review 8.  Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury.

Authors:  Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Cells       Date:  2019-09-23       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.